Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Meyskens

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 16, 2007
Cancer following total joint arthroplastyFrank Meyskens
JAMA Oncology|February 17, 2018
Oregon's Death With Dignity Act-ReplyCharles Blanke, Lee Ellis, Frank Meyskens
Cancer Causes & Control : CCC|March 11, 2018
A cancer registry-based analysis on the non-white populations reveals a critical role of the female sex in early-onset melanomaTze-An Yuan, Frank Meyskens, Feng Liu-Smith
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 2, 2012
Cancer prevention for global health: a report from the ASPO International Cancer Prevention Interest GroupDejana Braithwaite, Paolo Boffetta, Timothy R Rebbeck, et al.
JAMA Oncology|April 7, 2017
Characterizing 18 Years of the Death With Dignity Act in OregonCharles Blanke, Michael LeBlanc, Dawn Hershman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 10, 2010
Opportunities for cancer epidemiology and control in low- and middle-income countries: a report from the american society for preventive oncology international cancer prevention interest groupDejana Braithwaite, Karen J Wernli, Hoda Anton-Culver, et al.
Cancer Treatment and Research|November 26, 2015
Melanoma Epidemiology and PreventionMarianne Berwick, David B Buller, Anne Cust, et al.
The Lancet. Oncology|May 5, 2009
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statementJack Cuzick, Florian Otto, John A Baron, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 6, 2011
Phase IIA trial testing erlotinib as an intervention against intraductal pancreatic mucinous neoplasmsSteven Lipkin, John Lee, David Imagawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanomaSanjiv S Agarwala, John Glaspy, Steven J O'Day, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 16, 2007
Cancer following total joint arthroplastyFrank Meyskens
JAMA Oncology|February 17, 2018
Oregon's Death With Dignity Act-ReplyCharles Blanke, Lee Ellis, Frank Meyskens
Cancer Causes & Control : CCC|March 11, 2018
A cancer registry-based analysis on the non-white populations reveals a critical role of the female sex in early-onset melanomaTze-An Yuan, Frank Meyskens, Feng Liu-Smith
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 2, 2012
Cancer prevention for global health: a report from the ASPO International Cancer Prevention Interest GroupDejana Braithwaite, Paolo Boffetta, Timothy R Rebbeck, et al.
JAMA Oncology|April 7, 2017
Characterizing 18 Years of the Death With Dignity Act in OregonCharles Blanke, Michael LeBlanc, Dawn Hershman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 10, 2010
Opportunities for cancer epidemiology and control in low- and middle-income countries: a report from the american society for preventive oncology international cancer prevention interest groupDejana Braithwaite, Karen J Wernli, Hoda Anton-Culver, et al.
Cancer Treatment and Research|November 26, 2015
Melanoma Epidemiology and PreventionMarianne Berwick, David B Buller, Anne Cust, et al.
The Lancet. Oncology|May 5, 2009
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statementJack Cuzick, Florian Otto, John A Baron, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 6, 2011
Phase IIA trial testing erlotinib as an intervention against intraductal pancreatic mucinous neoplasmsSteven Lipkin, John Lee, David Imagawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanomaSanjiv S Agarwala, John Glaspy, Steven J O'Day, et al.
Pageof 2